Search results for "Intratympanic gentamicin"

showing 3 items of 3 documents

Decision making for solitary vestibular schwannoma and contralateral Meniere's disease.

2007

The existence of dual inner ear pathology such as unilateral Meniere’s disease (MD) with a contralateral vestibular schwannoma (VS) is very rare, but provides the otologist with a significant management dilemma. In this study, we present 5 cases of unilateral disabling MD with a contralateral VS in the better hearing ear. Conservative management of the VS is mandated unless there are impending complications, with management directed toward controlling the vertigo attributed to MD. If and when the VS requires intervention, or the hearing in that ear deteriorates to unserviceable levels, cochlear implant of the ear affected by MD prior to addressing the VS provides optimal management.

Malemedicine.medical_specialtyPhysiologymedicine.medical_treatmentDecision MakingSchwannomaAudiologyIntratympanic gentamicin Vestibular schwannoma Meniere's diseaseFunctional LateralitySpeech and HearingAudiometryVertigoCochlear implantotorhinolaryngologic diseasesmedicineHumansHearing LossMeniere DiseaseAntibacterial agentAgedVestibular systembiologymedicine.diagnostic_testbusiness.industryNeuroma AcousticMiddle Agedmedicine.diseasebiology.organism_classificationVestibular nerveSensory SystemsSurgeryCochlear ImplantsOtorhinolaryngologyFemalesense organsAudiometrybusinessMeniere's diseaseAudiologyneuro-otology
researchProduct

Intratympanic gentamicin: a 1-day protocol treatment for unilateral Meniere's disease

2006

Abstract Purpose The objective of this study was to assess the usefulness of low-dose intratympanic gentamicin administration in patients with Meniere's disease (MD). Materials and Methods We carried out a retrospective review of the charts of 55 patients with definite MD in accordance with the AAO-HNS (American Academy of Otolaryngology–Head and Neck Surgery) Diagnostic Scale who were treated at Gruppo Otologico (Piacenza, Rome, Italy). The treatment protocol consisted of 3 intratympanic injections of gentamicin at a 12-hour interval between each administration. Results Results were resumed in accordance with AAO-HNS criteria and showed complete control of vertigo spells in 60% (class A), …

inner earAdultMalemedicine.medical_specialtyTympanic MembranegentamicinInjectionsIntratympanic gentamicinvertigoAudiometryQuality of lifeVertigomedicineHumansMeniere DiseaseAgedRetrospective StudiesAntibacterial agentbiologybusiness.industryAminoglycosideMiddle Agedmedicine.diseasebiology.organism_classificationAnti-Bacterial AgentsSurgeryTreatment OutcomeOtorhinolaryngologyPoor controlFemaleGentamicinGentamicinsbusinessMeniere's diseasemedicine.drugAmerican Journal of Otolaryngology
researchProduct

Intratympanic gentamicin: a one day protocol treatment for unilateral Meniere’s disease.

2007

Purpose: The objective of this study was to assess the usefulness of low-dose intratympanic gentamicin administration in patients with Meniere’s disease (MD). Materials and Methods: We carried out a retrospective review of the charts of 55 patients with definite MD in accordance with the AAO-HNS (American Academy of Otolaryngology–Head and Neck Surgery) Diagnostic Scale who were treated at Gruppo Otologico (Piacenza, Rome, Italy). The treatment protocol consisted of 3 intratympanic injections of gentamicin at a 12-hour interval between each administration. Results: Results were resumed in accordance with AAO-HNS criteria and showed complete control of vertigo spells in 60% (class A), good c…

vertigoIntratympanic gentamicinEndolymphatic hydropsgentamicinMeniere’s disease
researchProduct